ASH2014

Loading viewer...

report

Format: PDF report

This report discusses the clinical activity of Indatuximab Ravtansine (BT062) combined with Lenalidomide in treating relapsed multiple myeloma patients.

Browse all reports →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Biotest

View all →

presentation

Similar reports from other companies

Browse all →

report

CIMIC Group

report

Kimberly-Clark